AdvanceBiotechCentrusCROPharmaceuticalPre-ClinicalRegulatory SubmissionRegulatory SubmissionsSENDSEND Advantage Services
Reusing SEND Data for ICH S1B Submissions: Faster, Cost-Effective Carcinogenicity Assessments
Mike Thurogood, CMktr
In this article, we explore how SEND data can be used in data gathering for WoE submissions and the key time and cost benefits for sponsors looking to streamline their submissions.
